logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-8. New and all clients entering treatment for primary use of amphetamines, ecstasy and other non-cocaine stimulants in 2005 for countries supplying data [see all tables in this series...]

Part(ii) New clients of all treatment centres reported for the country

CountryAmphetamines%Ecstasy%Other stimulants%Total
Bulgaria787.5112.500.008
Czech Republic260599.2160.660.232627
Denmark16484.13115.900.00195
Ireland2219.39280.700.00114
Greece00.0240.0360.005
Spain(1)23650.118338.95211.04471
France814.84685.200.0054
Italy3511.128188.900.00316
Cyprus133.3266.700.003
Latvia9586.476.487.27110
Hungary37950.031641.7638.31758
Malta00.06100.000.006
Netherlands30169.49020.7439.91434
Portugal00.01292.317.6913
Romania18.31191.700.0012
Slovenia(1)116.7583.300.006
Slovakia29099.031.000.00293
Finland18396.800.063.17189
Sweden33397.492.600.00342
United Kingdom(2)161971.156424.8954.172278
Turkey11.46998.600.0070
Total628175.6174621.02773.348304

Notes:

 All treatment centres included. 

 Only countries supplying data were reported. 

 Percentage of drugs is percentage from all stimulants. 

 (1) Last data available refer to 2004. 

 (2) Data collection period refer to 01.04.2004 to 31.03.2005. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - ST03. 

Page last updated: Monday, 12 November 2007